If you have been reading about Tietze assay and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-09-06. Numbers and descriptions here follow the published literature rather than marketing material.
Several analytical methods can quantify glutathione, including high-performance liquid chromatography (HPLC) with UV or fluorescence detection for separating GSH and GSSG. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers higher specificity and sensitivity, often detecting nanomolar concentrations. The enzymatic recycling assay, often called the Tietze method, measures total glutathione by coupling reduction of GSSG to a colorimetric or fluorometric readout. Capillary electrophoresis and electrochemical detection are also used in specialized laboratories. Each method has distinct advantages and limitations regarding throughput, cost, and susceptibility to interference.
Interpreting glutathione measurements requires attention to pre-analytical variables. The GSSG concentration in a sample can rise artificially during storage or processing, making the GSH/GSSG ratio unreliable if not controlled. Reference ranges vary by specimen type, assay, and population, so comparisons across studies are difficult. Plasma glutathione is low and sensitive to hemolysis, while whole blood reflects primarily erythrocyte content. Many studies measure total glutathione rather than the reduced and oxidized forms separately, which limits conclusions about redox status.
Glutathione is a tripeptide composed of glutamate, cysteine, and glycine. Its cysteine residue carries a thiol group, which allows the molecule to participate in reduction and oxidation reactions. The compound exists in most living cells, where the reduced form, often abbreviated GSH, is usually more abundant than the oxidized disulfide form, GSSG. Intracellular concentrations are commonly in the millimolar range, while extracellular concentrations are much lower. This uneven distribution supports its role as a major cellular redox buffer.
Cells synthesize glutathione through two ATP-dependent enzymatic steps. The first step combines glutamate and cysteine to form gamma-glutamylcysteine, catalyzed by glutamate-cysteine ligase. The second step adds glycine, producing the complete tripeptide, catalyzed by glutathione synthetase. Glutathione itself can inhibit the first enzyme, providing negative feedback when levels are high. Because cysteine is often limiting, its availability influences how quickly the pathway proceeds. These reactions occur in the cytosol, and the resulting glutathione can be distributed to other compartments.
| Property | Value | Notes |
|---|---|---|
| Common analytical method | LC-MS/MS or HPLC | Separation of GSH and GSSG |
| Limit of detection | Nanomolar range | Method dependent |
| Typical sample storage | -80 °C | For biological matrices |
| Common reducing agent | TCEP or DTT | Prevents oxidation during processing |
| Common synonym | Gamma-glutamylcysteinylglycine | Systematic name |
=== Obesity === Octreotide has been used experimentally to treat obesity, particularly obesity caused by lesions in the hunger and satiety centers of the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure. The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus (LH) and ventromedial hypothalamus (VMH), the brain's feeding and satiety centers, respectively. The ventromedial hypothalamus is sometimes injured by ongoing treatment for acute lymphoblastic leukemia or surgery or radiation to treat posterior cranial fossa tumors. With the ventromedial hypothalamus disabled and no longer responding to peripheral energy balance signals, "Efferent sympathetic activity drops, resulting in malaise and reduced energy expenditure, and vagal activity increases, resulting in increased insulin secretion and adipogenesis." "VMH dysfunction promotes excessive caloric intake and decreased caloric expenditure, leading to continuous and unrelenting weight gain. Attempts at caloric restriction or pharmacotherapy with adrenergic or serotonergic agents have previously met with little or only brief success in treating this syndrome." In this context, octreotide suppresses the excessive release of insulin and may increase its action, thereby inhibiting excessive adipose storage.
Transporter competition: Many GalNAc-conjugated siRNA drugs (e.g., inclisiran, givosiran, lumasiran) are taken up by hepatocytes via the asialoglycoprotein receptor (ASGPR). Co-administration of agents that saturate or alter this receptor pathway may affect hepatic delivery of the siRNA payload. Carrier protein binding: Some oligonucleotide drugs bind serum albumin or lipoproteins. Competition with highly protein-bound small molecules could alter free-drug concentrations. Indirect CYP modulation: siRNA drugs that silence transcription factors controlling CYP gene expression (e.g., silencing of PCSK9 influences LXR/SREBP pathways) may indirectly alter CYP expression in co-treated patients. On-target miRNA network perturbation: Because endogenous microRNA (miRNA) regulates the expression of drug-metabolizing enzymes and transporters, therapeutic oligonucleotides that modulate miRNA activity can produce secondary DDIs via altered enzyme expression rather than direct enzyme binding.
== Research == LeBlanc is most known for his contributions to the field of environmental health sciences, focusing his research on the effects of environmental contaminants on human and environmental health. With a particular emphasis on endocrine-disrupting compounds, his research has centered on exploring the mechanisms of action and toxicological properties of diverse environmental chemicals. In his book, Everyday Chemicals: Understanding the Risks, he has provided details into the potential health risks associated with chemicals to which people are commonly exposed and has given a nontechnical overview of the essential factors involved in assessing whether exposure to chemicals in everyday lives could cause harm.
Sources: en.wikipedia.org
=== Emerging diseases === In most cases, microorganisms live in harmony with their hosts via mutual or commensal interactions. Diseases can emerge when existing parasites become pathogenic or when new pathogenic parasites enter a new host.
In January 2006, Hitchens joined with four other individuals and four organisations, including the American Civil Liberties Union and Greenpeace, as plaintiffs in a lawsuit, ACLU v. NSA, challenging Bush's warrantless domestic spying program; the lawsuit was filed by the ACLU.
AABB (Association for the Advancement of Blood & Biotherapies) is an international, not-for-profit organization representing individuals and institutions involved in the field of transfusion medicine and biotherapies. The association works collaboratively to advance the field through the development and delivery of standards, accreditation and education programs. AABB is dedicated to its mission of improving lives by making transfusion medicine and biotherapies safe, available and effective worldwide. The association was founded in the United States in 1947 as the American Association of Blood Banks. In 2021, it changed its name to Association for the Advancement of Blood & Biotherapies to better reflect its mission and work. Virtually all blood banks in the United States are accredited by AABB. In addition, AABB accredits hospital transfusion services, biotherapies facilities, cord blood banks, relationship testing facilities, and various other facilities whose work relates to blood and biotherapies. Accreditation by AABB meets the requirements of the Clinical Laboratory Improvement Amendments (CLIA) for blood bank, transfusion service, and immunohematology reference laboratory operations. AABB hosts an annual meeting every fall for the dissemination of research and information for the blood and biotherapies field. The association publishes a monthly magazine, a weekly newsletter, and a peer-reviewed research journal titled Transfusion.
Sources: en.wikipedia.org
Glutathione oxidizes quickly when cells are disrupted or when samples sit at room temperature. Rapid processing or immediate freezing minimizes the conversion of GSH to GSSG. This step helps ensure that the measured ratio reflects the original biological state.
The Tietze assay is an enzymatic recycling method that measures total glutathione. It uses glutathione reductase to reduce GSSG back to GSH, which then reacts with a chromogen or fluorophore. The reaction cycles repeatedly, amplifying the signal for detection.
Yes, but the choice of blood fraction matters. Plasma or serum contains low glutathione levels and is easily affected by hemolysis. Whole blood mainly reflects the high glutathione content of erythrocytes, so results from different fractions are not directly comparable.
Glutathione is built from three amino acids: glutamate, cysteine, and glycine. The linkage involves the gamma-carboxyl group of glutamate rather than the alpha-carboxyl group, which is unusual for peptides. This structure protects the bond from some common peptidases.